Positioned at the intersection of technology, research, and responsible healthcare, HIGGS strives to create high-quality pharmaceutical formulations that meet national and international safety, efficacy, and regulatory benchmarks.
With a diverse portfolio of formulations and a quality-first manufacturing ecosystem, HIGGS provides reliable, effective, and safe medicines across India and emerging global markets. Our strategic investments in advanced equipment, compliant facilities, quality control laboratories, and strong R&D enable us to ensure consistent quality across every therapeutic category we operate in.
As part of the diversified Virgo Group, HIGGS represents the Group’s expansion into high-value healthcare and pharmaceutical formulations. This strategic move not only strengthens Virgo’s business verticals but also reinforces the organization’s vision of contributing meaningfully to global health outcomes.
Beyond manufacturing, HIGGS contributes to improved healthcare accessibility through efficient supply chains, patient-friendly formulations, and partnerships with trusted healthcare institutions.
HIGGS ensures world-class pharmaceutical production supported by technology-driven systems and robust quality frameworks.
| Key Facility Capabilities |
|---|
| WHO-GMP compliant infrastructure |
| Temperature & humidity-controlled production zones |
| HEPA-filtered cleanrooms (Class 100–10,000) |
| Automated filling & packaging lines |
| Laminar airflow stations |
| In-process testing & batch validation |
| Dedicated sterile manufacturing areas |
| High-capacity HVAC systems |
| Water-for-injection (WFI) generation systems |
| Comprehensive documentation & traceability |
| Each manufacturing batch is certified through in-house QC labs equipped with: |
|---|
| Microbiology labs |
| Analytical chemistry labs |
| Stability chambers |
| HPLC, UV spectrophotometers, sterility testers |
Delivered with Confidence.
.svg)
.svg)
Every product follows a “Quality by Design” approach, integrating safety and compliance right from raw material testing to finished goods dispatch.
HIGGS R&D acts as the core engine driving innovation and high-quality formulation enhancement.
The R&D team constantly monitors global pharma trends, ICH guidelines, and new therapeutic opportunities to introduce robust, science-driven formulations.
We are building strong partnerships with healthcare providers, ensuring that our products reach patients in urban, semi-urban, and rural markets.
HIGGS prioritizes responsible operations that protect the environment and community health.
Our ESG-aligned mindset ensures long-term environmental stewardship.
Yes. Higgs Pharma products are developed for pharmaceutical, healthcare, and hygiene-sensitive environments.